Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,321 papers from all fields of science
Search
Sign In
Create Free Account
CDISC Questionnaire EDSS Test Name Terminology
Known as:
EDSS01TN
, Kurtzke Expanded Disability Status Scale Questionnaire Test Name
, QS-EDSS TEST
Test names of questionnaire questions associated with the Kurtzke Expanded Disability Status Scale (EDSS) for the Clinical Data Interchange Standards…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Traitement de la sclérose en plaques par natalizumab : expérience du service de neurologie du CHU d’Oran
Naima Oudrer
,
A. Aidi
,
Laid Oubaiche Mohand
Revue neurologique (Paris)
2019
Corpus ID: 109233875
2017
2017
Ametyst - výsledky observační studie fáze IV sledující účinky intramuskulárně podávaného interferonu beta 1-a u pacientů s klinicky izolovaným syndromem/klinicky definitivní roztroušenou sklerózou
P. Štourač
,
D. Horáková
,
Eleonóra Klímová
,
Peter Turcani
2017
Corpus ID: 80489341
Cil: Primarnim cilem studie AMETYST bylo stanovit vliv lecby na parametry kvality života hodnocene pacientem pomoci vizualni…
Expand
2013
2013
Immunomodulatory therapy of multiple sclerosis in adolescents:single-center experience
K. Kupczyk
,
B. Steinborn
2013
Corpus ID: 39908383
STRESZCZENIE Wstep. Stwardnienie rozsiane (SM, lac. sclerosis multiplex) jest przewleklą zapalno-immmunologiczną chorobą o…
Expand
2012
2012
Therapieziele von Basis- und Eskalationstherapien zur Behandlung der schubförmig-remittierenden Multiplen Sklerose
R. Gold
,
H. Hartung
,
M. Stangel
,
H. Wiendl
,
F. Zipp
,
für die Teilnehmer eines Expertenmeetings
Aktuelle Neurologie
2012
Corpus ID: 76404607
Zusammenfassung Vor dem Hintergrund der Verfügbarkeit neuer, hochwirksamer MS-Therapeutika und der besonderen Bedeutung des fr…
Expand
2011
2011
Ionenkanalmodulatoren bei Multipler Sklerose
S. Bittner
,
K. Höhn
,
K. Göbel
,
C. Kleinschnitz
,
H. Wiendl
,
S. Meuth
Der Nervenarzt
2011
Corpus ID: 9547354
ZusammenfassungHintergrundAufgrund vielgestaltiger Symptome erhalten Patienten mit Diagnose einer Multiplen Sklerose (MS) neben…
Expand
2009
2009
ENCEPHALOMYELITIS Clinical features , HLA DRB 1 * 1501 , HLA DRB 1 * 1503 , HLA DQA 1 * 0102 , HLA DQB 1 * 0602 , and HLA DPA 1 * 0301 allelic association study
S. Alves‐Leon
,
Maria Lucia Veluttini-Pimentel
,
+5 authors
T. Quirico-Santos
2009
Corpus ID: 16642350
We evaluated the frequency, demographic, clinical, disability evolution and genetic association of HLA DRB1*1501, DRB1*1503, DQA1…
Expand
Review
2001
Review
2001
February 13 Highlights
L. Wilkins
Neurology
2001
Corpus ID: 196499728
Transcranial magnetic stimulation (TMS) activates the underlying brain relays and networks without risk or pain. Rossini and…
Expand
1998
1998
Safety and Tolerability of Subcutaneous Cladribine Therapy in Progressive Multiple Sclerosis
R. Selby
,
J. Brandwein
,
P. O'Connor
Canadian Journal of Neurological Sciences…
1998
Corpus ID: 20968780
ABSTRACT: Objective: To evaluate the safety and tolerability of subcutaneous (s.c.) cladribine therapy in patients with chronic…
Expand
1997
1997
Interferon-beta 1a in der Therapie der schubförmigen multiplen Sklerose
H. Hartung
,
R. Hohlfeld
Der Nervenarzt
1997
Corpus ID: 42943291
Die Krankheitsprogredienz war bei IFNβ1a behandelten Patienten nach einer Kaplan-Meier-Analyse signifikant verzögert im Vergleich…
Expand
1995
1995
Is it possible to achieve cross-cultural european agreement in the assessment of neurological deficits? First experiences in the european interferon-beta 1B trial for secondary progressive MS
J. Lechner-Scott
,
H. Brunnschweiler
,
L. Kappos
,
The Study Steering Committee
Journal of Neuroimmunology
1995
Corpus ID: 53182528
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE